Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL778367 | 0.83 | TSHR (0.59) | HTTALDH1A1KDM4EMAPK1HSD17B10 | |
| SCHEMBL8885835 | 0.80 | TSHR (0.69) | HTTALDH1A1KDM4ETSHRGAA | |
| SCHEMBL13625149 | 0.79 | SMN1; SMN2 (0.58) | ALDH1A1KDM4EMAPK1LMNAMEN1 | |
| SCHEMBL14503351 | 0.79 | LMNA (0.62) | HTTALDH1A1KDM4ETSHRLMNA | |
| SCHEMBL15836257 | 0.78 | TSHR (0.58) | HTTALDH1A1KDM4ETSHRGAA | |
| SCHEMBL28769756 | 0.77 | LMNA (0.67) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL4132657 | 0.76 | LMNA (0.76) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL14503998 | 0.76 | ALDH1A1 (0.53) | HTTALDH1A1KDM4EMAPK1HSD17B10 | |
| SCHEMBL1443735 | 0.74 | LMNA (0.61) | HTTALDH1A1KDM4EMAPK1HSD17B10 | |
| SCHEMBL8054495 | 0.73 | ALDH1A1 (0.78) | HTTALDH1A1KDM4EMAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281215-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281215-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | PSMB5, POLL, F12 | HTT 2832/4885ALDH1A1 2014/4885KDM4E 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.